These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3025983)

  • 1. Plasma concentrations of angiotensin II and aldosterone during acute left ventricular failure in the dog. Effect of converting enzyme inhibition.
    Hall C; Karlberg BE
    Res Exp Med (Berl); 1986; 186(5):387-95. PubMed ID: 3025983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ACE-inhibition on tissue blood flow during acute left ventricular failure in the dog.
    Hall C; Mørkrid L; Kjekshus J
    Res Exp Med (Berl); 1987; 187(1):59-70. PubMed ID: 3033782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased bradykinin levels accompany the hemodynamic response to acute inhibition of angiotensin-converting enzyme in dogs with heart failure.
    Su JB; Barbe F; Crozatier B; Campbell DJ; Hittinger L
    J Cardiovasc Pharmacol; 1999 Nov; 34(5):700-10. PubMed ID: 10547087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of angiotensin and renin inhibition in dogs with acute left ventricular failure.
    Sweet CS; Ludden CT; Frederick CM; Ribeiro LG
    Am J Med; 1984 Aug; 77(2A):7-12. PubMed ID: 6089558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enalaprilat, a new parenteral angiotensin-converting enzyme inhibitor: rapid changes in systemic and coronary hemodynamics and humoral profile in chronic heart failure.
    De Marco T; Daly PA; Liu M; Kayser S; Parmley WW; Chatterjee K
    J Am Coll Cardiol; 1987 May; 9(5):1131-8. PubMed ID: 3033043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between angiotensin receptor antagonism and converting enzyme inhibition in heart failure. Differential acute effects according to the renin-angiotensin system activation.
    Su J; Barbe F; Houël R; Guyene TT; Crozatier B; Hittinger L
    Basic Res Cardiol; 1999 Apr; 94(2):128-35. PubMed ID: 10326661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional cerebral blood flow during acute left ventricular failure in the dog: effect of converting enzyme inhibition.
    Hall C; Mørkrid L; Zwetnow NN
    Eur Surg Res; 1988; 20(5-6):373-80. PubMed ID: 2852110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enalaprilat: an intravenous substitute for oral enalapril therapy. Humoral and pharmacokinetic effects.
    Reams GP; Lal SM; Whalen JJ; Bauer JH
    J Clin Hypertens; 1986 Sep; 2(3):245-53. PubMed ID: 3023555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hemodynamic and hormonal effects of lisinopril (MK-521) in congestive heart failure.
    Dickstein K; Aarsland T; Woie L; Abrahamsen AM; Fyhrquist F; Cummings S; Gomex HJ; Hagen E; Kristianson K
    Am Heart J; 1986 Jul; 112(1):121-9. PubMed ID: 3014850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative hemodynamic effects of MK-422, a converting enzyme inhibitor, and a renin inhibitor in dogs with acute left ventricular failure.
    Sweet CS; Ludden CT; Frederick CM; Bush LR; Ribeiro LG
    J Cardiovasc Pharmacol; 1984; 6(6):1067-75. PubMed ID: 6084762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic, hormonal, and pharmacokinetic aspects of treatment with lisinopril in congestive heart failure.
    Dickstein K
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S73-81. PubMed ID: 2442558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of low dose aspirin on cardiorenal function and acute hemodynamic response to enalaprilat in a canine model of severe heart failure.
    Evans MA; Burnett JC; Redfield MM
    J Am Coll Cardiol; 1995 May; 25(6):1445-50. PubMed ID: 7722147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
    MacFadyen RJ; Lee AF; Morton JJ; Pringle SD; Struthers AD
    Heart; 1999 Jul; 82(1):57-61. PubMed ID: 10377310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unrelated responses of brachial artery hemodynamics and renin-angiotensin system to acute converting enzyme inhibition by enalaprilat in essential hypertension.
    Levenson J; Chau NP; Billaud E; Simon A
    Am J Cardiol; 1988 May; 61(13):1056-60. PubMed ID: 2834938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of the clinical pharmacology of enalapril.
    Davies RO; Gomez HJ; Irvin JD; Walker JF
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):215S-229S. PubMed ID: 6099737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enalapril in experimental hypertension and acute heart failure: comparison with calcium channel blockers.
    Sweet CS; Ludden CT; Adkins E; Seymour AA; Emmert S; Ribeiro LG
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S15-9. PubMed ID: 2422487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of spiraprilat, an angiotensin-converting enzyme inhibitor, on anesthetized dogs in a new model of acute left ventricular failure.
    Nakazawa M; Ishihara T; Takahashi Y; Okuhira M; Imai S
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):585-93. PubMed ID: 7505361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure.
    Shen YT; Wiedmann RT; Greenland BD; Lynch JJ; Grossman W
    Cardiovasc Res; 1998 Aug; 39(2):413-22. PubMed ID: 9798526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.